| Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a … A Di Leo, S Johnston, KS Lee, E Ciruelos, PE Lønning, W Janni, ... The Lancet Oncology 19 (1), 87-100, 2018 | 400 | 2018 |
| Abstract S4-07: BELLE-3: a phase III study of buparlisib+ fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic … A Di Leo, K Seok Lee, E Ciruelos, P Lønning, W Janni, R O'Regan, ... Cancer Research 77 (4_Supplement), S4-07-S4-07, 2017 | 62 | 2017 |
| Namodenoson in advanced hepatocellular carcinoma and Child–Pugh B cirrhosis: randomized placebo-controlled clinical trial SM Stemmer, NS Manojlovic, MV Marinca, P Petrov, N Cherciu, D Ganea, ... Cancers 13 (2), 187, 2021 | 37 | 2021 |
| A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A3 adenosine receptor agonist (A3AR … SM Stemmer, NS Manojlovic, MV Marinca, P Petrov, N Cherciu, D Ganea, ... Journal of Clinical Oncology 37 (15_suppl), 2503-2503, 2019 | 10 | 2019 |
| CECOG experts’ recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer W Hilbe, U Abacioglu, DM Aebersold, M Bachouchi, T Brodowicz, ... memo-Magazine of European Medical Oncology 6, 75-82, 2013 | 2 | 2013 |
| First line 5-FU-based chemotherapy with/without bevacizumab for metastatic colorectal cancer: one center experience results A Konsoulova, I Donev, N Conev, S Draganova, T Chervenkov, N Petrova, ... Scripta Scientifica Medica 47, 20-25, 2015 | | 2015 |
| 2-year single center clinical experience in patients with colon cancer stage II and III receiving adjuvant chemotherapy NV Conev, IS Donev, E Dimitrova, M Kozhuharova, M Georgieva, ... Scripta Scientifica Medica 47 (2), 43-48, 2015 | | 2015 |
| Personalized medication therapy in patients with aN advanced lung adenocarcinoma E Dimitrova, D Kalev Scripta Scientifica Medica 46 (1), 2014 | | 2014 |
| Abstracts of the 20th annual meeting of the associationHeart-Lungand 2nd †žVarna-Augsburgconference 30-31 may 2014 P Manoilov, P Panayotov, K Yankov, E Dimitrova, D Kalev, Y Krasnaliev, ... Scripta Scientifica Medica 46 (1), 1-42, 2014 | | 2014 |
| Functional Results and Oncological Outcome of Radical Prostatectomy Used as a Primary Treatment in Locally Advanced Prostate Cancer A Hinev, D Anakievski, V Hadjiev, A Angelov, L Marinova, D Kalev UROLOGY 80 (3), S272-S272, 2012 | | 2012 |
| Impact of seminal vesicle invasion on oncological outcome after radical prostatectomy DK Hinev A., I. Krasnaliev, L. Marinova Urology 74 (Suppl 4A), S132, 2009 | | 2009 |
| Cell adhesion molecules in pleural effusions with different etiology I Micheva, D Kalev, G Georgiev Biomedical Reviews 6, 121-123, 1996 | | 1996 |
| DIAGNOCTIC ALGORITHM FOR BRONCHIAL ASTHMA S Projkov, M Peneva, Z Zlatanov, D Kalev Scripta Scientifica Medica 28, 35-36, 1991 | | 1991 |
| BRONCHOALVEOLAR LAVAGE IN THE DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF LUNG DISEASES H Ganchev, M Kokoshyan, D Kalev Scripta Scientifica Medica 28, 39-40, 1991 | | 1991 |
| LITERARY EMERGENTISM D KALEV | | |
